Clinical trials
Completed Heart Diseases trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
372 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 5 |
| 2001 | 5 |
| 2002 | 10 |
| 2003 | 12 |
| 2004 | 17 |
| 2005 | 12 |
| 2006 | 15 |
| 2007 | 10 |
| 2008 | 8 |
| 2009 | 10 |
| 2010 | 14 |
| 2011 | 14 |
| 2012 | 18 |
| 2013 | 16 |
| 2014 | 17 |
| 2015 | 7 |
| 2016 | 15 |
| 2017 | 24 |
| 2018 | 16 |
| 2019 | 20 |
| 2020 | 20 |
| 2021 | 20 |
| 2022 | 14 |
| 2023 | 18 |
| 2024 | 17 |
| 2025 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 372 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | 13 |
| Duke University | 8 |
| University of Edinburgh | 8 |
| Abbott Medical Devices | 5 |
| Rigshospitalet, Denmark | 5 |
| University Health Network, Toronto | 5 |
| University of Pittsburgh | 5 |
| Brigham and Women's Hospital | 4 |
| Johns Hopkins University | 4 |
| OrbusNeich | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heart Diseases | 372 |
| Cardiovascular Diseases | 124 |
| Hypertension | 36 |
| Heart Failure | 35 |
| Obesity | 35 |
| Diabetes Mellitus | 33 |
| Coronary Artery Disease | 30 |
| Coronary Disease | 26 |
| Arrhythmias, Cardiac | 21 |
| Myocardial Ischemia | 20 |
Trials
Showing 1 to 25 of 372. Each trial links to its page on Pharma Observatory.
272 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.